Results 91 to 100 of about 34,707 (224)

Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 2, March 2026.
SGLT2 inhibitor therapy was associated with a significantly lower risk of the composite outcome of all‐cause mortality or heart failure hospitalization at one year, as well as each component individually. ABSTRACT Background Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular (CV) outcomes in patients with heart failure (HF) and ...
Shaikh Muhammad Daniyal, Naveen Murad Khatoon, Anas Rasool, Isbah Gul, Sabula Tabish, Shireen Asifa, Ayan Khalid, Zunaira Aftab, Muhammad Burhan, Syeda Laiba Fahim, Habiba Tauqir Gondal, Muhammad Asfandyar Nadir, Syed Zaeem Ahmed, Danish Ali Ashraf, Somaiya Ahmed   +14 more
wiley   +1 more source

Natural History of Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background To determine the impact of tricuspid regurgitation (TR) on outcomes after transcatheter aortic valve implantation (TAVI), and to determine the evolution of TR severity after TAVI.
James A. Brown, Jack Donohue, Sarah Yousef, Nidhi Iyanna, Danial Ahmad, Dustin Kliner, Catalin Toma, Derek Serna‐Gallegos, Amber Makani, David West, Irsa Hasan, Takuya Ogami, Ibrahim Sultan   +12 more
doaj   +1 more source

Transapical transcatheter aortic valve implantation: The Berlin experience [PDF]

Scripta Medica, 2012
Transcatheter aortic valve implantation (TAVI) has been recently introduced as a means to treat patients with severe aortic valve stenosis at high risk or rejected for conventional surgery. In the present manuscript we summarize the Deutsches Herzzentrum
D'ancona Giuseppe, Pasic Miralem, Drews Thorsten, Buz Semih, Dreysse Stephan, Unbehaun Axel, Hetzer Roland   +6 more
doaj  

Kathetergestützte Aortenklappenimplantation: Was müssen Anästhesisten wissen? [PDF]

, 2018
Zusammenfassung: Der chirurgische Aortenklappenersatz gilt als Goldstandard in der Therapie der hochgradigen Aortenklappenstenose. Die veränderte Demografie konfrontiert die behandelnden medizinischen Fachdisziplinen jedoch mit einem zunehmend höheren ...
Fassl, J., Nietlispach, F., Riediger, C., Rüter, F.   +3 more
core  

From Tumor Marker to Congestion Indicator: The Expanding Role of CA‐125 in Heart Failure and Beyond

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims To evaluate the transition of Carbohydrate antigen 125 (CA‐125) from an ovarian tumor marker to a versatile indicator of systemic congestion and fluid overload. Methods A literature review (1984–2025) was conducted using PubMed, Scopus, and Web of Science. Keywords included “CA‐125,” “systemic congestion,” and related terms.
Minoo Heidari Almasi, Seyed Amirhossein Salehi, Azin Ebrahimi, Ladan Heidaresfahani, Amirahmad Nassiri   +4 more
wiley   +1 more source

Computational study of the excitation of human induced pluripotent stem cell‐derived cardiomyocytes

Experimental Physiology, Volume 111, Issue 3, Page 1008-1038, 1 March 2026.
Abstract Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) have proven to be a revolutionary advance for tissue engineering, disease modelling, and drug testing and discovery. Computational modelling enables detailed electrophysiological analysis that is otherwise difficult or impossible to achieve under strictly experimental ...
Roshni Shetty, Raffi Samurkashian, Leslie Tung   +2 more
wiley   +1 more source

Transcatheter Aortic Valve Implantation: Insights into Clinical Complications [PDF]

, 2014
__Abstract__ Transcatheter Aortic Valve Implantation (TAVI) has emerged as a viable and safe treatment for patients with severe aortic stenosis (AS) who are considered ineligible or at prohibitive risk for Surgical Aortic Valve Replacement (SAVR)1–4.
Boon, R.M.A. (Robert) van der
core   +1 more source

Antithrombotic therapy in TAVI.

Journal of geriatric cardiology : JGC, 2018
Transcatheter aortic valve implantation (TAVI) carries a significant thromboembolic and concomitant bleeding risk, not only during the procedure but also during the periprocedural period. Many issues concerning optimal antithrombotic therapy after TAVI are still under debate.
Vavuranakis, M., Kalogeras, K., Kolokathis, A.M., Vrachatis, D., Magkoutis, N., Siasos, G., Oikonomou, E., Kariori, M., Papaioannou, T., Lavda, M., Moldovan, C., Katsarou, O., Tousoulis, D.   +12 more
openaire   +3 more sources

TAVI in Complex Dual-Level Obstruction: A Case of Severe Aortic Stenosis and Subaortic Membrane

Methodist DeBakey Cardiovascular Journal
This case addresses the challenges of treating patients with both severe aortic stenosis and subaortic stenosis. In this combined condition, transcatheter aortic valve implantation (TAVI) remains an off-label application, particularly in the presence of ...
Salem Assiri, Mohammed S. Alshammakh, Sultan M. Alzahrani, Moath Said Alfawara, Khaled Al-Shaibi   +4 more
doaj   +1 more source

Snorkel Stenting During Transcatheter Aortic Valve Implantation: A Single-Center Study

Medicina
Background and Objectives: Coronary obstruction (CO) is a potentially fatal complication that can occur during transcatheter aortic valve implantation (TAVI). The snorkel stenting technique was developed to mitigate the risk of CO. The aim of the current
Massimo Baudo, Serge Sicouri, Yoshiyuki Yamashita, Dimitrios E. Magouliotis, Francesco Cabrucci, Sarah M. Carnila, Scott M. Goldman, Eric M. Gnall, William A. Gray, Sandro Gelsomino, Basel Ramlawi   +10 more
doaj   +1 more source